Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

117 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Burden of schizophrenia on selected comorbidity costs.
Lafeuille MH, Dean J, Fastenau J, Panish J, Olson W, Markowitz M, Duh MS, Lefebvre P. Lafeuille MH, et al. Expert Rev Pharmacoecon Outcomes Res. 2014 Apr;14(2):259-67. doi: 10.1586/14737167.2014.894463. Epub 2014 Mar 5. Expert Rev Pharmacoecon Outcomes Res. 2014. PMID: 24593801
Incremental direct and indirect costs of untreated vasomotor symptoms.
Sarrel P, Portman D, Lefebvre P, Lafeuille MH, Grittner AM, Fortier J, Gravel J, Duh MS, Aupperle PM. Sarrel P, et al. Among authors: lafeuille mh. Menopause. 2015 Mar;22(3):260-6. doi: 10.1097/GME.0000000000000320. Menopause. 2015. PMID: 25714236
Burden of systemic glucocorticoid-related complications in severe asthma.
Lefebvre P, Duh MS, Lafeuille MH, Gozalo L, Desai U, Robitaille MN, Albers F, Yancey S, Ortega H, Forshag M, Lin X, Dalal AA. Lefebvre P, et al. Among authors: lafeuille mh. Curr Med Res Opin. 2017 Jan;33(1):57-65. doi: 10.1080/03007995.2016.1233101. Epub 2016 Oct 14. Curr Med Res Opin. 2017. PMID: 27627132
An Evaluation of Treatment Patterns and Outcomes in Elderly Patients Newly Diagnosed With Acute Myeloid Leukemia: A Retrospective Analysis of Electronic Medical Records From US Community Oncology Practices.
Ma E, Bonthapally V, Chawla A, Lefebvre P, Swords R, Lafeuille MH, Fortier J, Emond B, Duh MS, Dezube BJ. Ma E, et al. Among authors: lafeuille mh. Clin Lymphoma Myeloma Leuk. 2016 Nov;16(11):625-636.e3. doi: 10.1016/j.clml.2016.08.006. Epub 2016 Aug 10. Clin Lymphoma Myeloma Leuk. 2016. PMID: 27686689 Free article.
Treatment patterns and outcomes with subcutaneous bortezomib in patients with relapsed mantle cell lymphoma: a retrospective, observational study of patient medical records from US community oncology practices.
Skarbnik AP, Ma E, Lafeuille MH, Fortier J, Feldman T, Duh MS, van de Velde H, Niculescu L, Bonthapally V, Goy A. Skarbnik AP, et al. Among authors: lafeuille mh. Leuk Lymphoma. 2017 Aug;58(8):1968-1972. doi: 10.1080/10428194.2016.1272688. Epub 2017 Jan 16. Leuk Lymphoma. 2017. PMID: 28092998 No abstract available.
Real-world adherence and economic outcomes associated with paliperidone palmitate versus oral atypical antipsychotics in schizophrenia patients with substance-related disorders using Medicaid benefits.
Joshi K, Lafeuille MH, Kamstra R, Tiggelaar S, Lefebvre P, Kim E, Yue Y, Tandon N. Joshi K, et al. Among authors: lafeuille mh. J Comp Eff Res. 2018 Feb;7(2):121-133. doi: 10.2217/cer-2017-0043. Epub 2017 Aug 15. J Comp Eff Res. 2018. PMID: 28809128 Free article.
Real-world evaluation of Hba1c, blood pressure, and weight loss among patients with type 2 diabetes mellitus treated with canagliflozin: an analysis of electronic medical records from a network of hospitals in Florida.
Tanton D, Duh MS, Lafeuille MH, Lefebvre P, Pilon D, Zhdanava M, Emond B, Inman D, Bailey RA. Tanton D, et al. Among authors: lafeuille mh. Curr Med Res Opin. 2018 Jun;34(6):1099-1115. doi: 10.1080/03007995.2018.1444591. Epub 2018 Mar 5. Curr Med Res Opin. 2018. PMID: 29468896
Quality goal attainment and maintenance in patients with type II diabetes mellitus initiated on canagliflozin or a glucagon-like peptide-1 receptor agonist in an actual practice setting.
Wysham CH, Pilon D, Ingham M, Lafeuille MH, Emond B, Kamstra R, Pfeifer M, Lefebvre P. Wysham CH, et al. Among authors: lafeuille mh. Curr Med Res Opin. 2018 Jun;34(6):1125-1133. doi: 10.1080/03007995.2018.1454417. Epub 2018 Mar 27. Curr Med Res Opin. 2018. PMID: 29557199
Development of predictive risk models for major adverse cardiovascular events among patients with type 2 diabetes mellitus using health insurance claims data.
Young JB, Gauthier-Loiselle M, Bailey RA, Manceur AM, Lefebvre P, Greenberg M, Lafeuille MH, Duh MS, Bookhart B, Wysham CH. Young JB, et al. Among authors: lafeuille mh. Cardiovasc Diabetol. 2018 Aug 24;17(1):118. doi: 10.1186/s12933-018-0759-z. Cardiovasc Diabetol. 2018. PMID: 30143045 Free PMC article.
Burden of disease associated with a COPD eosinophilic phenotype.
Ortega H, Llanos JP, Lafeuille MH, Germain G, Duh MS, Bell CF, Sama SR, Hahn B. Ortega H, et al. Among authors: lafeuille mh. Int J Chron Obstruct Pulmon Dis. 2018 Aug 13;13:2425-2433. doi: 10.2147/COPD.S170995. eCollection 2018. Int J Chron Obstruct Pulmon Dis. 2018. PMID: 30147308 Free PMC article.
An investigation into the durability of glycemic control in patients with type II diabetes initiated on canagliflozin or sitagliptin: A real-world analysis of electronic medical records.
Wysham CH, Lefebvre P, Pilon D, Lafeuille MH, Emond B, Kamstra R, Pfeifer M, Duh MS, Ingham M. Wysham CH, et al. Among authors: lafeuille mh. J Diabetes Complications. 2019 Feb;33(2):140-147. doi: 10.1016/j.jdiacomp.2018.10.016. Epub 2018 Oct 31. J Diabetes Complications. 2019. PMID: 30554838 Free article.
Real-world impact of glycated hemoglobin reduction on treatment intensification and glycated hemoglobin goal attainment in type 2 diabetes mellitus patients initiated on a sodium glucose co-transporter 2 (SGLT2) inhibitor (SGLT2i).
Brunton S, Rozjabek HM, Pilon D, Lafeuille MH, Kamstra R, Wynant W, Bookhart BK, Lefebvre P. Brunton S, et al. Among authors: lafeuille mh. Curr Med Res Opin. 2019 Sep;35(9):1607-1614. doi: 10.1080/03007995.2019.1605160. Epub 2019 May 3. Curr Med Res Opin. 2019. PMID: 30964362
Costs and Treatment Patterns Among Patients with Atopic Dermatitis Using Advanced Therapies in the United States: Analysis of a Retrospective Claims Database.
Eichenfield LF, DiBonaventura M, Xenakis J, Lafeuille MH, Duh MS, Fakih I, Levenberg M, Cappelleri JC, Sikirica V. Eichenfield LF, et al. Among authors: lafeuille mh. Dermatol Ther (Heidelb). 2020 Aug;10(4):791-806. doi: 10.1007/s13555-020-00413-8. Epub 2020 Jun 30. Dermatol Ther (Heidelb). 2020. PMID: 32607738 Free PMC article.
Identification of patients with metastatic castration-sensitive or metastatic castration-resistant prostate cancer using administrative health claims and laboratory data.
Freedland SJ, Ke X, Lafeuille MH, Romdhani H, Kinkead F, Lefebvre P, Petrilla A, Pulungan Z, Kim S, D'Andrea DM, Francis P, Ryan CJ. Freedland SJ, et al. Among authors: lafeuille mh. Curr Med Res Opin. 2021 Apr;37(4):609-622. doi: 10.1080/03007995.2021.1879753. Epub 2021 Feb 13. Curr Med Res Opin. 2021. PMID: 33476184 Review.
Medication adherence, healthcare resource utilization, and costs among Medicaid beneficiaries with schizophrenia treated with once-monthly paliperidone palmitate or once-every-three-months paliperidone palmitate.
Lin D, Pilon D, Zhdanava M, Joshi K, Lafeuille MH, Côté-Sergent A, Vermette-Laforme M, Lefebvre P. Lin D, et al. Among authors: lafeuille mh. Curr Med Res Opin. 2021 Apr;37(4):675-683. doi: 10.1080/03007995.2021.1882412. Epub 2021 Feb 13. Curr Med Res Opin. 2021. PMID: 33507838
Real-World Evidence of the Clinical and Economic Impact of Long-Acting Injectable Versus Oral Antipsychotics Among Patients with Schizophrenia in the United States: A Systematic Review and Meta-Analysis.
Lin D, Thompson-Leduc P, Ghelerter I, Nguyen H, Lafeuille MH, Benson C, Mavros P, Lefebvre P. Lin D, et al. Among authors: lafeuille mh. CNS Drugs. 2021 May;35(5):469-481. doi: 10.1007/s40263-021-00815-y. Epub 2021 Apr 28. CNS Drugs. 2021. PMID: 33909272 Free PMC article.
Weight Change and Predictors of Weight Change Among Patients Initiated on Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide or Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Real-World Retrospective Study.
Emond B, Rossi C, Côté-Sergent A, Dunn K, Lefebvre P, Lafeuille MH, Donga P. Emond B, et al. Among authors: lafeuille mh. J Health Econ Outcomes Res. 2021 Jun 14;8(1):88-98. doi: 10.36469/001c.24535. J Health Econ Outcomes Res. 2021. PMID: 34179212 Free PMC article.
Treatment Patterns Among Patients With Mantle Cell Lymphoma and Comparison of Healthcare Resource Utilization and Costs Among Relapsed/Refractory Patients Treated With Ibrutinib or Chemoimmunotherapy: A Real-world Retrospective Study.
Ghosh N, Emond B, Lafeuille MH, Côté-Sergent A, Lefebvre P, Huang Q. Ghosh N, et al. Among authors: lafeuille mh. Clin Ther. 2021 Aug;43(8):1285-1299. doi: 10.1016/j.clinthera.2021.06.012. Epub 2021 Jul 29. Clin Ther. 2021. PMID: 34332789 Free article.
Body mass index increase and weight gain among people living with HIV-1 initiated on single-tablet darunavir/cobicistat/emtricitabine/tenofovir alafenamide or bictegravir/emtricitabine/tenofovir alafenamide in the United States.
Emond B, Rossi C, Côté-Sergent A, Bookhart B, Anderson D, Lefebvre P, Lafeuille MH, Donga P. Emond B, et al. Among authors: lafeuille mh. Curr Med Res Opin. 2022 Feb;38(2):287-298. doi: 10.1080/03007995.2021.2007006. Epub 2021 Dec 7. Curr Med Res Opin. 2022. PMID: 34812097
Real-World Analysis of Weight Gain and Body Mass Index Increase Among Patients with HIV-1 Using Antiretroviral Regimen Containing Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate, or Neither in the United States.
Emond B, Rossi C, Rogers R, Lefebvre P, Lafeuille MH, Donga P. Emond B, et al. Among authors: lafeuille mh. J Health Econ Outcomes Res. 2022 Feb 14;9(1):39-49. doi: 10.36469/jheor.2022.31825. eCollection 2022. J Health Econ Outcomes Res. 2022. PMID: 35233432 Free PMC article.
Patient characteristics, treatment patterns, and outcomes among black and white patients with multiple myeloma initiating daratumumab: A real-world chart review study.
Atrash S, Thompson-Leduc P, Tai MH, Kaila S, Gray K, Ghelerter I, Lafeuille MH, Jayabalan D, Lefebvre P, Rossi A. Atrash S, et al. Among authors: lafeuille mh. Clin Lymphoma Myeloma Leuk. 2022 Aug;22(8):e708-e715. doi: 10.1016/j.clml.2022.03.014. Epub 2022 Mar 29. Clin Lymphoma Myeloma Leuk. 2022. PMID: 35490154 Free article.
Real-World Persistence and Time to Next Treatment With Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Including Patients at High Risk for Atrial Fibrillation or Stroke.
Narezkina A, Akhter N, Lu X, Emond B, Panjabi S, Forbes SP, Hilts A, Liu S, Lafeuille MH, Lefebvre P, Huang Q, Choi M. Narezkina A, et al. Among authors: lafeuille mh. Clin Lymphoma Myeloma Leuk. 2022 Nov;22(11):e959-e971. doi: 10.1016/j.clml.2022.07.004. Epub 2022 Jul 15. Clin Lymphoma Myeloma Leuk. 2022. PMID: 35973891 Free article.
[No title available]
[No authors listed] [No authors listed] PMID: 36163889
[No title available]
[No authors listed] [No authors listed] PMID: 36163895
Healthcare Resource Utilization and Costs in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer Receiving First-Line Treatment in the United States: An Insurance Claims-Based Descriptive Analysis.
Vanderpoel J, Emond B, Ghelerter I, Milbers K, Lafeuille MH, Lefebvre P, Ellis LA. Vanderpoel J, et al. Among authors: lafeuille mh. Pharmacoecon Open. 2023 Jul;7(4):617-626. doi: 10.1007/s41669-023-00407-0. Epub 2023 Apr 19. Pharmacoecon Open. 2023. PMID: 37074589 Free PMC article.
Treatment Patterns and Predictors of Adherence in HIV Patients Receiving Single- or Multiple-Tablet Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide.
Chow W, Donga P, Côté-Sergent A, Rossi C, Lefebvre P, Lafeuille MH, Hardy H, Emond B. Chow W, et al. Among authors: lafeuille mh. Patient Prefer Adherence. 2020 Nov 23;14:2315-2326. doi: 10.2147/PPA.S272211. eCollection 2020. Patient Prefer Adherence. 2020. PMID: 33262581 Free PMC article.
Correction to: Real-World Evidence of the Clinical and Economic Impact of Long-Acting Injectable Versus Oral Antipsychotics Among Patients with Schizophrenia in the United States: A Systematic Review and Meta-Analysis.
Lin D, Thompson-Leduc P, Ghelerter I, Nguyen H, Lafeuille MH, Benson C, Mavros P, Lefebvre P. Lin D, et al. Among authors: lafeuille mh. CNS Drugs. 2021 Aug;35(8):923. doi: 10.1007/s40263-021-00850-9. CNS Drugs. 2021. PMID: 34347273 Free PMC article. No abstract available.
Correction to: Treatment patterns and effectiveness of patients with multiple myeloma initiating Daratumumab across different lines of therapy: a real-world chart review study.
Atrash S, Thompson-Leduc P, Tai MH, Kaila S, Gray K, Ghelerter I, Lafeuille MH, Lefebvre P, Rossi A. Atrash S, et al. Among authors: lafeuille mh. BMC Cancer. 2021 Dec 2;21(1):1291. doi: 10.1186/s12885-021-09015-9. BMC Cancer. 2021. PMID: 34856934 Free PMC article. No abstract available.
Incidence and economic burden of respiratory syncytial virus among adults in the United States: A retrospective analysis using 2 insurance claims databases.
Mesa-Frias M, Rossi C, Emond B, Bookhart B, Anderson D, Drummond S, Wang J, Lefebvre P, Lamerato LE, Lafeuille MH. Mesa-Frias M, et al. Among authors: lafeuille mh. J Manag Care Spec Pharm. 2022 Jul;28(7):753-765. doi: 10.18553/jmcp.2022.21459. Epub 2022 May 3. J Manag Care Spec Pharm. 2022. PMID: 35503888
Cost Savings of Expedited Care with Upfront Next-Generation Sequencing Testing versus Single-Gene Testing among Patients with Metastatic Non-Small Cell Lung Cancer Based on Current Canadian Practices.
Sheffield BS, Eaton K, Emond B, Lafeuille MH, Hilts A, Lefebvre P, Morrison L, Stevens AL, Ewara EM, Cheema P. Sheffield BS, et al. Among authors: lafeuille mh. Curr Oncol. 2023 Feb 15;30(2):2348-2365. doi: 10.3390/curroncol30020180. Curr Oncol. 2023. PMID: 36826141 Free PMC article.
Association Between Weight Gain and the Incidence of Cardiometabolic Conditions Among People Living with HIV-1 at High Risk of Weight Gain Initiated on Antiretroviral Therapy.
McComsey GA, Emond B, Shah A, Bookhart BK, Rossi C, Milbers K, Lafeuille MH, Donga P. McComsey GA, et al. Among authors: lafeuille mh. Infect Dis Ther. 2022 Oct;11(5):1883-1899. doi: 10.1007/s40121-022-00673-1. Epub 2022 Aug 2. Infect Dis Ther. 2022. PMID: 35917003 Free PMC article.
Progression-Free Survival of Daratumumab Versus Bortezomib Triplet Combination With Lenalidomide and Dexamethasone in Transplant Ineligible Patients With Newly Diagnosed Multiple Myeloma: TAURUS Chart Review Study.
Gordan LN, Tan CR, Vescio R, Ye JC, Schinke C, Medhekar R, Fu AZ, Lafeuille MH, Thompson-Leduc P, Khare V, Reitan J, Milkovich G, Kaila S, Davies F, Usmani SZ. Gordan LN, et al. Among authors: lafeuille mh. Clin Lymphoma Myeloma Leuk. 2024 Jan;24(1):55-63. doi: 10.1016/j.clml.2023.09.003. Epub 2023 Sep 14. Clin Lymphoma Myeloma Leuk. 2024. PMID: 37838502 Free article.
Incidence of cardiometabolic outcomes among people living with HIV-1 initiated on integrase strand transfer inhibitor versus non-integrase strand transfer inhibitor antiretroviral therapies: a retrospective analysis of insurance claims in the United States.
Rebeiro PF, Emond B, Rossi C, Bookhart BK, Shah A, Caron-Lapointe G, Lafeuille MH, Donga P. Rebeiro PF, et al. Among authors: lafeuille mh. J Int AIDS Soc. 2023 Jun;26(6):e26123. doi: 10.1002/jia2.26123. J Int AIDS Soc. 2023. PMID: 37306118 Free PMC article.
Cost of genetic testing, delayed care, and suboptimal treatment associated with polymerase chain reaction versus next-generation sequencing biomarker testing for genomic alterations in metastatic non-small cell lung cancer.
Bestvina CM, Waters D, Morrison L, Emond B, Lafeuille MH, Hilts A, Lefebvre P, He A, Vanderpoel J. Bestvina CM, et al. Among authors: lafeuille mh. J Med Econ. 2024 Jan-Dec;27(1):292-303. doi: 10.1080/13696998.2024.2314430. Epub 2024 Feb 24. J Med Econ. 2024. PMID: 38391239 Free article.
Weight and BMI Changes Following Initiation of Emtricitabine/Tenofovir Alafenamide Co-Formulated with Darunavir or Co-Administered with Dolutegravir in Overweight or Obese, ART-Naïve People Living with HIV-1.
Donga P, Emond B, Rossi C, Bookhart BK, Lee J, Caron-Lapointe G, Wei F, Lafeuille MH. Donga P, et al. Among authors: lafeuille mh. Clinicoecon Outcomes Res. 2023 Jul 24;15:579-591. doi: 10.2147/CEOR.S413800. eCollection 2023. Clinicoecon Outcomes Res. 2023. PMID: 37521004 Free PMC article.
Treatment outcomes, health-care resource utilization and costs of bortezomib and dexamethasone, with cyclophosphamide or lenalidomide, in newly diagnosed multiple myeloma.
Kumar SK, Ma E, Engebretson AE, Buadi FK, Lacy MQ, Dispenzieri A, Duh MS, Lafeuille MH, Lefebvre P, Cheng WY, Dea K, Rembert D, Patt D, Niculescu L, Quick M, Rajkumar SV. Kumar SK, et al. Among authors: lafeuille mh. Leukemia. 2016 Apr;30(4):995-8. doi: 10.1038/leu.2015.225. Epub 2015 Aug 14. Leukemia. 2016. PMID: 26271606 No abstract available.